Zobrazeno 1 - 10
of 63
pro vyhledávání: '"A, Bousoulegas"'
Autor:
George Hatzitheoharis, Eleni Nenopoulou, Aris Bousoulegas, E. Briassoulis, George Basdanis, Urania Dafni, Nicholaos Karvounis, Christos Konstantaras, Paris Kosmidis, Eleftherios Giannoulis, Constantine Katsohis, John Dokmetzioglou, Alkis Zisiadis, Gerassimos Aravantinos, George Fountzilas, Spyros Papavramidis, Dimosthenis Skarlos, Nicholas Pavlidis
Publikováno v:
Oncology. 58:227-236
Background: It has been shown in randomized studies that adjuvant treatment with the combination of fluorouracil (FU) and levamisole reduced the risk of recurrence and deaths of patients with stage III colon cancer. Pharmacological studies of FU led
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2bfb39299c04013675da86c3f8e3eec2
https://doi.org/10.1159/000012105
https://doi.org/10.1159/000012105
Publikováno v:
Breast Cancer Research : BCR
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e54b91829368d147c54bf936806d332d
https://doi.org/10.1186/bcr2296
https://doi.org/10.1186/bcr2296
Publikováno v:
European journal of gynaecological oncology. 24(6)
To co-evaluate DNA analysis and the expression of c-erb B-2 and p53 oncoproteins with the histologic type and the other known prognostic factors of breast cancer.Sixty-five imprint smears from breast surgical specimens were examined by immunocytochem
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::851871fdf9e7cca644512a3c0f5f2cf9
https://pubmed.ncbi.nlm.nih.gov/14658596
https://pubmed.ncbi.nlm.nih.gov/14658596
Autor:
G, Fountzilas, A, Zisiadis, U, Dafni, C, Konstantaras, G, Hatzitheoharis, S, Papavramidis, A, Bousoulegas, G, Basdanis, E, Giannoulis, J, Dokmetzioglou, C, Katsohis, E, Nenopoulou, N, Karvounis, E, Briassoulis, G, Aravantinos, P, Kosmidis, D, Skarlos, N, Pavlidis
Publikováno v:
Oncology. 58(3)
It has been shown in randomized studies that adjuvant treatment with the combination of fluorouracil (FU) and levamisole reduced the risk of recurrence and deaths of patients with stage III colon cancer. Pharmacological studies of FU led to its use i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::5cfc9b0e2f87e5ae6fbed0c1c88fd128
https://pubmed.ncbi.nlm.nih.gov/10765125
https://pubmed.ncbi.nlm.nih.gov/10765125
Autor:
Fountzilas, George, Zisiadis, A., Dafni, U., Konstantaras, C., Hatzitheoharis, G., Papavramidis, S., Bousoulegas, A., Basdanis, G., Giannoulis, E., Dokmetzioglou, J., Katsohis, C., Nenopoulou, E., Karvounis, N., Briassoulis, E. Ch, Aravantinos, Gerasimos, Kosmidis, Paraskevas A., Skarlos, Dimosthenis V., Pavlidis, Nicholas
Publikováno v:
Oncology
Background: It has been shown in randomized studies that adjuvant treatment with the combination of fluorouracil (FU) and levamisole reduced the risk of recurrence and deaths of patients with stage III colon cancer. Pharmacological studies of FU led
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______4485::22be249eca5f0cb893a0051c0ed9dc96
https://gnosis.library.ucy.ac.cy/handle/7/41685
https://gnosis.library.ucy.ac.cy/handle/7/41685
Background: It has been shown in randomized studies that adjuvant treatment with the combination of fluorouracil (FU) and levamisole reduced the risk of recurrence and deaths of patients with stage III colon cancer. Pharmacological studies of FU led
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::efb93cb604eb64c7aae3804def0c4563
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3052822
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3052822
Autor:
Fountzilas, G., Zisiadis, A., Dafni, U., Konstantaras, C., Hatzitheoharis, G., Papavramidis, S., Bousoulegas, A., Basdanis, G., Giannoulis, E., Dokmetzioglou, J., Katsohis, C., Nenopoulou, E., Karvounis, N., Briassoulis, E., Aravantinos, G., Kosmidis, P., Skarlos, D., Pavlidis, N.
BACKGROUND: It has been shown in randomized studies that adjuvant treatment with the combination of fluorouracil (FU) and levamisole reduced the risk of recurrence and deaths of patients with stage III colon cancer. Pharmacological studies of FU led
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_____10561::6cc4ab55d0e5b271701fcc72471852ee
http://olympias.lib.uoi.gr/jspui/handle/123456789/21535
http://olympias.lib.uoi.gr/jspui/handle/123456789/21535
Publikováno v:
European Journal of Cancer Supplements. 6:77-78
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f5b387f4b45836d8bb43dafcbcc49a87
https://doi.org/10.1016/s1359-6349(08)70414-2
https://doi.org/10.1016/s1359-6349(08)70414-2
Publikováno v:
European Journal of Cancer Supplements. 7:296
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::10247205e7514120d3d80314db6f8dca
https://doi.org/10.1016/s1359-6349(09)71014-6
https://doi.org/10.1016/s1359-6349(09)71014-6
Publikováno v:
Breast Cancer Research : BCR
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::36ec1de17b8409fed4d3c77abe475b77
http://europepmc.org/articles/PMC4284900
http://europepmc.org/articles/PMC4284900